RCWM
RVNC

Royal Capital Wealth Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Royal Capital Wealth Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,875
Closed -$221K – 102
2023
Q1 		$221K Buy
+6,875
New +$221K 0.22% 86